BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30872624)

  • 21. Nucleosome-CHD4 chromatin remodeler structure maps human disease mutations.
    Farnung L; Ochmann M; Cramer P
    Elife; 2020 Jun; 9():. PubMed ID: 32543371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.
    Liu Y; Ji W; Shergalis A; Xu J; Delaney AM; Calcaterra A; Pal A; Ljungman M; Neamati N; Rehemtulla A
    Cancer Res; 2019 Jun; 79(11):2923-2932. PubMed ID: 30996048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage.
    Larsen DH; Poinsignon C; Gudjonsson T; Dinant C; Payne MR; Hari FJ; Rendtlew Danielsen JM; Menard P; Sand JC; Stucki M; Lukas C; Bartek J; Andersen JS; Lukas J
    J Cell Biol; 2010 Sep; 190(5):731-40. PubMed ID: 20805324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose).
    Silva AP; Ryan DP; Galanty Y; Low JK; Vandevenne M; Jackson SP; Mackay JP
    J Biol Chem; 2016 Jan; 291(2):924-38. PubMed ID: 26565020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM.
    Brett-Morris A; Wright BM; Seo Y; Pasupuleti V; Zhang J; Lu J; Spina R; Bar EE; Gujrati M; Schur R; Lu ZR; Welford SM
    Cancer Res; 2014 Dec; 74(23):6925-34. PubMed ID: 25277523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications.
    Gobin M; Nazarov PV; Warta R; Timmer M; Reifenberger G; Felsberg J; Vallar L; Chalmers AJ; Herold-Mende CC; Goldbrunner R; Niclou SP; Van Dyck E
    Cancer Res; 2019 Mar; 79(6):1226-1238. PubMed ID: 30674534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.
    Tachon G; Cortes U; Guichet PO; Rivet P; Balbous A; Masliantsev K; Berger A; Boissonnade O; Wager M; Karayan-Tapon L
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-224 expression increases radiation sensitivity of glioblastoma cells.
    Upraity S; Kazi S; Padul V; Shirsat NV
    Biochem Biophys Res Commun; 2014 May; 448(2):225-30. PubMed ID: 24785373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.
    Hoffmeister H; Fuchs A; Erdel F; Pinz S; Gröbner-Ferreira R; Bruckmann A; Deutzmann R; Schwartz U; Maldonado R; Huber C; Dendorfer AS; Rippe K; Längst G
    Nucleic Acids Res; 2017 Oct; 45(18):10534-10554. PubMed ID: 28977666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
    Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
    Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma.
    Gil Del Alcazar CR; Todorova PK; Habib AA; Mukherjee B; Burma S
    Mol Cancer Res; 2016 Oct; 14(10):928-940. PubMed ID: 27358111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors.
    Helness A; Fraszczak J; Joly-Beauparlant C; Bagci H; Trahan C; Arman K; Shooshtarizadeh P; Chen R; Ayoub M; Côté JF; Oeffinger M; Droit A; Möröy T
    Commun Biol; 2021 Dec; 4(1):1356. PubMed ID: 34857890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
    Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
    Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.
    Kitange GJ; Mladek AC; Schroeder MA; Pokorny JC; Carlson BL; Zhang Y; Nair AA; Lee JH; Yan H; Decker PA; Zhang Z; Sarkaria JN
    Cell Rep; 2016 Mar; 14(11):2587-98. PubMed ID: 26972001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.